Latest News about RXRX
Recent news which mentions RXRX
From InvestorPlace
3 Stocks to Buy for Their Proximity to Nvidia
November 08, 2023
From InvestorPlace
Why Fortinet Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Friday's Mid-Day Session
November 03, 2023
From Benzinga
The 7 Best Cathie Wood Stocks to Buy Now: November Edition
November 01, 2023
From InvestorPlace
2 Reasons to Buy Recursion Pharmaceuticals, and 1 Reason to Sell
October 31, 2023
Tickers
RXRX
From Motley Fool
3 Extra-Speculative Stocks That Could Make You Very, Very Rich
October 26, 2023
From InvestorPlace
2 Risky Stocks With Massive Potential
October 17, 2023
From Motley Fool
From Motley Fool
2 Cathie Wood Stocks I'm Bullish On
October 05, 2023
From Motley Fool
2 AI Stocks That Aren't Worth the Hype
October 04, 2023
From Motley Fool
Cathie Wood's Ark Invest Sells Nearly $4M Worth Of NVIDIA Shares — Does It Herald Shift To Undervalued AI Gems?
October 02, 2023
From Benzinga
2 Cathie Wood Stocks That Could Deliver Exponential Returns
October 02, 2023
From Motley Fool
Immunomics Stocks: 3 Ways to Play This Massive AI-Biotech Megatrend
September 22, 2023
From InvestorPlace
3 Stocks Cathie Wood Is Buying That Should Be on Your List, Too
September 22, 2023
From Motley Fool
Better Growth Stock: Recursion Pharmaceuticals vs. CRISPR Therapeutics
September 15, 2023
From Motley Fool
3 AI Drug Discovery Stocks to Watch
September 15, 2023
From Motley Fool
2 Growth Stocks That Could Rocket 88% to 99% Higher According to Wall Street
September 12, 2023
From Motley Fool
AI Integration In Biotech & Pharma: Companies Positioned To Benefit
September 11, 2023
From Benzinga
Where Will Recursion Pharmaceuticals Be in 3 Years?
September 11, 2023
Tickers
RXRX
From Motley Fool
Recursion Pharmaceuticals has a prescription for high drug costs: AI and 25 petabytes of data
September 08, 2023
From MarketWatch
From Motley Fool
3 Biotech Stocks to Invest In for Big-Time, Long-Term Gains
September 05, 2023
From InvestorPlace
Cathie Wood Just Sold Nvidia -- and Bought These 5 Potentially Explosive Growth Stocks Again
August 30, 2023
From Motley Fool
Better AI Biotech Stock: Recursion Pharmaceuticals vs. 23andMe
August 25, 2023
From Motley Fool
Cathie Wood's Ark Invest Adjusts Portfolio — Sells Nvidia Shares Worth Nearly $1.9M Amid AI Surge
August 24, 2023
From Benzinga
Cathie Wood Just Sold Shopify -- and Bought These 7 Potentially Explosive Growth Stocks
August 24, 2023
From Motley Fool
3 Clever Tricks to Find Winning Biotech Stocks
August 24, 2023
From Motley Fool